Since the menstrual cycle of patients with GTN before chemotherapy is influenced by the β hCG level, the FSH level may be of limited use for assessing ovarian reserve during chemotherapy considering that it is usually measured during the early follicular phase. The gene discussed is BRD2; the disease is gestational trophoblastic neoplasm.